NEW YORK—Lippert/Heilshorn & Associates, which specializes in emerging growth companies, has won 10 new accounts for investor relations activities since the beginning of the year.
Six of the new accounts will be handled out of the company’s New York headquarters. LHA will develop and implement investor relations programs for PDI, a sales and marketing services provider to the biopharmaceutical industry; Industrial Enterprises of America, an automotive aftermarket supplier; and Perio-Imaging, creator of a probe system that detects periodontal disease. The firm will provide strategic counseling services and financial communications to EntreMed, a pharmaceutical company focused on multi-mechanism oncology; Ramtron International, a leading supplier of parallel ferroelectric random access memory devices; and NaviSite, a provider of application and technology services.
Three accounts will be managed from LHA’s Los Angeles office: Ligand Pharmaceuticals, an emerging specialty pharmaceutical company; Avanir Pharmaceuticals, a drug discovery and development company; and Delcath Systems, developer of a system used to administer chemotherapy directly to the liver. Majesco Entertainment, a provider of digital entertainment products, has also retained LHA to develop an IR campaign and will be managed from LHA’s San Francisco office.